Nemoto Kyorindo's GE-Nemoto Dual Shot Alpha, which features Body Weight Protocol (BWP), Linear Decay Protocol (LDP) and Dilution Phase Protocol. The BWP method tailors the protocol based on the patients weight and the contrast concentration. The LDP uses less contrast to deliver the same amount of enhancement, injection time and image quality as normal injector methods, said the company. The Dilution Phase Protocol delivers contrast and saline simultaneously, which is commonly used in cardiac imaging today.


Additional Content

News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Cardiac Imaging

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Time August 12, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
News | FDA

May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...

Time May 18, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
Subscribe Now